NCT00464646 · Interventional trial
Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer
Overall registry status Completed
Phase 2
Conditions Breast Cancer
Delaware Valley sites
- Albert Einstein Healthcare Network · Philadelphia, PA · Philadelphia County
- Kimmel Cancer Center at Jefferson · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory